Episode 74: Prescription Digital Therapeutics for Insomnia
Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Yuri Maricich, MD, MBA. [LISTEN TIME: 30 minutes]
Yuri Maricich, MD, MBA
Episode 74 of the NeurologyLive® Mind Moments® podcast is now live! Scroll down to listen or click here to subscribe on your favorite streaming service.
The Mind Moments® podcast features exclusive interviews with leaders in the field discussing the latest research and disease management strategies across the breadth of neurology, including epilepsy, multiple sclerosis, Parkinson disease, dementia, sleep disorders, and more.
Episode 74, "Prescription Digital Therapeutics for Insomnia," features an exclusive interview with Yuri Maricich, MD, MBA, internal medicine physician, and chief medical officer and head of development, Pear Therapeutics. He joined the show to discuss the current use of digital therapeutics in insomnia such as cognitive behavioral therapy, the state of education and treatment for the sleep disorder, some of the challenges in care, and more.
This episode is brought to you by Medical World News™. Check out new episodes of a variety of shows, airing every single day, only on medicalworldnews.com.
The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:
- Alzheimer Disease Agent Lecanemab Shows Reduction in CDR-Sum of Boxes in Clarity AD
- Verdiperstat Fails to Differentiate From Placebo in Critical HEALEY ALS Platform Trial
- AMX0035 Approved for the Treatment of ALS
- CNM-Au8 Shows Survival Benefit in HEALEY ALS Trial, But Fails to Meet End Points
Click here to subscribe to the Mind Moments® podcast. Be sure to leave a rating and review for the show. Thanks for listening!
Hoping to listen on your favorite podcast app? See below:
